NO974455L - Nye falvonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske blandinger som inneholder dem - Google Patents

Nye falvonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske blandinger som inneholder dem

Info

Publication number
NO974455L
NO974455L NO974455A NO974455A NO974455L NO 974455 L NO974455 L NO 974455L NO 974455 A NO974455 A NO 974455A NO 974455 A NO974455 A NO 974455A NO 974455 L NO974455 L NO 974455L
Authority
NO
Norway
Prior art keywords
alkyl
optionally substituted
alkoxy
optionally
aryl
Prior art date
Application number
NO974455A
Other languages
English (en)
Norwegian (no)
Other versions
NO974455D0 (no
Inventor
Alain Dhainaut
Guy Lewin
Emmanuel Canet
Michel Lonchampt
Yves Rolland
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO974455D0 publication Critical patent/NO974455D0/no
Publication of NO974455L publication Critical patent/NO974455L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO974455A 1996-09-27 1997-09-26 Nye falvonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske blandinger som inneholder dem NO974455L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9611808A FR2753969B1 (fr) 1996-09-27 1996-09-27 Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO974455D0 NO974455D0 (no) 1997-09-26
NO974455L true NO974455L (no) 1998-03-30

Family

ID=9496129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974455A NO974455L (no) 1996-09-27 1997-09-26 Nye falvonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske blandinger som inneholder dem

Country Status (18)

Country Link
US (1) US5889003A (pt)
EP (1) EP0832886B1 (pt)
JP (1) JPH10114766A (pt)
CN (1) CN1094936C (pt)
AT (1) ATE227712T1 (pt)
AU (1) AU728990B2 (pt)
BR (1) BR9704900A (pt)
CA (1) CA2216617C (pt)
DE (1) DE69717044T2 (pt)
DK (1) DK0832886T3 (pt)
ES (1) ES2187738T3 (pt)
FR (1) FR2753969B1 (pt)
HU (1) HUP9701588A3 (pt)
NO (1) NO974455L (pt)
NZ (1) NZ328858A (pt)
PL (1) PL322297A1 (pt)
PT (1) PT832886E (pt)
ZA (1) ZA978652B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE298566T1 (de) * 1995-09-11 2005-07-15 Osteoarthritis Sciences Inc Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
MY126544A (en) 1998-08-26 2006-10-31 Smithkline Beecham Corp Therapies for treating pulmonary diseases
CA2345311A1 (en) * 1998-09-24 2000-03-30 Kazutoshi Watanabe Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
DE60043318D1 (de) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
US6806257B1 (en) 1999-10-20 2004-10-19 Board Of Trustees Of Southern Illinois University Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators
US6334998B1 (en) 1999-12-07 2002-01-01 Parker Hughes Institute Estrogens for treating ALS
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
US6472436B1 (en) * 2000-07-17 2002-10-29 The Salk Institute For Biological Studies Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production
DE10104350A1 (de) * 2001-02-01 2002-08-14 Merck Patent Gmbh Verfahren zur Herstellung von Flavon Derivaten
DE10232595A1 (de) * 2002-07-18 2004-02-05 Merck Patent Gmbh Lichtschutzmittel
KR20050115331A (ko) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 불임증 포스포디에스터라제의 억제제
JP5058481B2 (ja) * 2005-11-28 2012-10-24 丸善製薬株式会社 角化細胞増殖剤、サイクリックａｍｐホスホジエステラーゼ阻害剤、及び保湿剤
EP2058310A4 (en) * 2006-09-01 2010-11-17 Kyorin Seiyaku Kk PYRAZOLOPYRIDINCARBOXYL ACID AMID DERIVATIVE AND THE DERIVATIVELY PHOSPHODIESTERASE (PDE) INHIBITOR
CN101148444A (zh) * 2006-09-20 2008-03-26 上海特化医药科技有限公司 黄酮衍生物、制备方法及应用
KR100930467B1 (ko) * 2007-06-07 2009-12-08 동아제약주식회사 점액분비를 촉진시키는 3',4',5-트리메톡시 플라본 유도체화합물, 그의 제조방법 및 약학적 용도
JP4559531B1 (ja) * 2009-12-03 2010-10-06 ウシオケミックス株式会社 ノビレチンの製造方法
CN103059005B (zh) * 2012-11-22 2015-04-22 中南民族大学 白杨素酰胺衍生物及其医药用途
CN105906598B (zh) * 2016-05-19 2018-05-08 江苏耐雀生物工程技术有限公司 白杨素衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623808B1 (fr) * 1987-12-01 1990-03-09 Adir Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2689127B1 (fr) * 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2748025B1 (fr) * 1996-04-25 1998-10-30 Adir Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
AU728990B2 (en) 2001-01-25
ES2187738T3 (es) 2003-06-16
FR2753969B1 (fr) 1998-10-30
HUP9701588A3 (en) 1999-03-01
NZ328858A (en) 1998-01-26
EP0832886B1 (fr) 2002-11-13
PL322297A1 (en) 1998-03-30
JPH10114766A (ja) 1998-05-06
CA2216617A1 (fr) 1998-03-27
FR2753969A1 (fr) 1998-04-03
US5889003A (en) 1999-03-30
HU9701588D0 (en) 1997-11-28
ATE227712T1 (de) 2002-11-15
CN1094936C (zh) 2002-11-27
DE69717044D1 (de) 2002-12-19
AU3927197A (en) 1998-04-02
HUP9701588A2 (hu) 1998-12-28
ZA978652B (en) 1998-03-27
CA2216617C (fr) 2002-12-03
BR9704900A (pt) 1998-10-27
CN1179422A (zh) 1998-04-22
PT832886E (pt) 2003-03-31
DE69717044T2 (de) 2003-07-24
NO974455D0 (no) 1997-09-26
DK0832886T3 (da) 2003-03-10
EP0832886A1 (fr) 1998-04-01

Similar Documents

Publication Publication Date Title
NO974455D0 (no) Nye falvonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske blandinger som inneholder dem
DK0576350T3 (da) Forgrenede alkylaminothiazolderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem
DE69918404D1 (de) Aminophenoxyessigsäure derivate als neuroschützende mittel
DE69333688D1 (de) Inhibitoren von c-amp phosphodiesterase
NO308360B1 (no) Nye benzisoksazol-forbindelser, fremgangsmÕter ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
BR9908764A (pt) Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica
AR019153A1 (es) Compuestos de beta-carbolina, composicion farmaceutica que los contiene, su uso para la manufactura de un medicamento y compuesto intermediario
DE69911798D1 (de) Bicyclische piperidin- und piperazin-verbindungen mit 5-ht6-rezeptor-affinität
EA200200417A1 (ru) Фармацевтически активные производные сульфонамида
HRP20021023B1 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
ES2116555T3 (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
BR9911300A (pt) Composto, composição farmacêutica, e, uso do composto
ES2172294T3 (es) Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
NO144927C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinuclidinderivater
DK0541263T3 (da) 5-Piperazinylalkyl-1,5-benzothiazepinoner, der er nyttige som calciumantagonister
DK185984D0 (da) Disubstituerede polymethyleniminer,fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende dem
DE59606328D1 (de) Verfahren zur Herstellung von gegebenenfalls 2-substituierten 5-Chlor-imidazol-4-carbaldehyden
FI862174A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara berbanderivat.
SE8504119D0 (sv) 6-aminometyl-furo-(3,4-c)pyridinderivat, deras framsstellning och farmaceutiska kompositioner innehallande dem
YU53392A (sh) Supstituisani 3-aminohinuklidini
TH57270B (th) อนุพันธ์ 2-ฟีนิลพิแรน-4-โอน
TH97636B (th) อนุพันธุ์เบนไซซาซีนและการใช้สารเหล่านี้

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application